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Introduction
Mevalonate kinase deficiency (MKD) is a recessively-
inherited autoinflammatory condition caused by loss-of-
functionMVK mutations. This gene encodes for the
enzyme mevalonate kinase (MVK), which catalyzes a
crucial step of the biosynthetic pathway of cholesterol
and isoprenoids. The partial deficiency of enzymatic
activity causes the Hyper-IgD and periodic fever syn-
drome (HIDS), whereas it complete deficiency provokes
the Mevalonic Aciduria (MA).
Objectives
The aim of this study was to describe the clinical and
genetic features of Spanish patients with MKD diagnosed
during the past 15 years.
Methods
The patients’ data as well as the outcome of the adminis-
tered treatments were collected from charts reviews. MVK
analysis was performed by Sanger-based sequencing.
Results
Forty-one patients from different Spanish hospitals were
included. Thirty-eight patients (92.7%) suffered from
HIDS and three patients (7.3%) from MA. The MKD diag-
nosis was established in all of them by the detection of
biallelic MVK mutations. Eighteen different MVK muta-
tions were detected, with the p.[(V377I)] and p.[(I268T)]
mutations as the most prevalent, accounting for 54.9% and
26.8% of mutated alleles, respectively. The majority of
these mutations (96.4%) were missense mutations. The
remainder mutations included premature stop (1.2%),
frameshift (1.2%), and splice site mutations (1.2%). In the
group of patients with HIDS (n: 38), twelve patients
(31.6%) carried homozygous genotypes and twenty-six
patients (68.4%) compound heterozygous genotypes. In
the group of HIDS patients with homozygous genotypes
(n= 12), ten patients (83.3%) carried the p.[(V377I)];
[(V377I)] genotype. By contrast, in the group of patients
with MA only one patient (33.3%) carried a homozygous
genotype (the p.[(I268T)];[(I268T)]).
From a clinical point of view, the median age at the dis-
ease onset was 6 months (range 0-408), and the median
duration of flares was 4.8 days (range 2-17.5). Mandatory
vaccinations were identified as triggering factors for
acute episodes in eleven patients (26.8%). The most pre-
valent manifestations during inflammatory episodes were
fever (80.5%), lymphadenopathies (70.7%), abdominal
pain (63.4%), diarrhea (58.5%), aphthous ulcers (53.7%)
and arthralgia (51.2%). AA amyloidosis was only detected
in one patient (2.4%), but had a severe course.
Conclusion
We herein provide a detailed description of the clinical and
genetic features of a Spanish cohort of MKD patients carry-
ing biallelic MVK mutations. Most of patients suffered
from the mild MKD phenotype, the HIDS syndrome. Two
prevalent MVK mutations, p.[(V377I)] and p.[(I268T)],
were found in our cohort, and fever and lymphadenopa-
thies were the most common features in enrolled patients.1Hospital Clinic, Barcelona, Spain
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